Skip to main content

Table 2 The rate of agreement among participants on the age at which the transition starts, transfer of care, readiness, and completion of the transition

From: Towards a standardized program of transitional care for adolescents with juvenile idiopathic arthritis for Turkey: a national survey study

Timing of transition steps

The ratio of agreement

Preparation of the transition process should start at 16–18 years old

64.6%

at 14–16 years old

31.2%

at 12–14 years old

4.2%

The first talk with the patient about the transition should be made at 12–14 years old.

62.5%

The transition program planning should start between 16 and 18 years.

95.8%

The transition visits should be made between 18 and 20 years.

60%

The transition process should be completed between 20–24 years.

52.7%

Statements for the transition readiness

 The timing of all transition steps until the age of 18 should be cleared during the transition planning step.

54.2%

 Parents’ new changing roles in the transition should be discussed.

75%

 The patient should be encouraged to answer questions about their illness, treatment, pain, education, and activities during visits after the age of 12.

70%

Statements for the transfer of care

 During the transfer visit, the logbook of the transition period and the epicrisis should be submitted to the adult rheumatology department.

95.8%

 The second visit should be made together with pediatric and adult rheumatologists in the adult rheumatology outpatient clinic.

75.1%

 The feedback of parents or patients on adult rheumatology care should be taken by pediatric rheumatology at the first or second transfer visit.

87.5%

 To ensure that the patient continues with adult rheumatology care until the age of 24, they should be seen annually in the pediatric rheumatology clinic after the transfer.

16.1%

Statements for the transition completion

 The last visit should only be conducted in the adult rheumatology clinic.

43.8%

 Make sure that the patient schedules follow-up appointments before concluding the transition process.

75%

 The patient should be seen alone in the visits after the transfer visit.a

43.8%

  1. aThis question was answered only by adult rheumatologists.